Safety and Immunogenicity of COVID-19 Vaccine, Inactivated in Healthy Population Aged From 3 to 11 Years
Clinical trial NCT05137418 · COMPLETED
Trial details
- NCT number
- NCT05137418
- Sponsor
- Sinovac Research and Development Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-27
- Primary completion
- 2023-01-27
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.